Related Experiment Video
Updated: May 25, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Specific α2-adrenoreceptor antagonists induce behavioural activation in the rat.
S L Dickinson1, B Gadie, I F Tulloch
1Reckitt and Colman Psychopharmacology Unit, The School of Medical Sciences, University Walk, Bristol, BS8 1TD.
Selective alpha(2)-adrenoreceptor antagonists like idazoxan induced behavioral activation in rats, but only in habituated animals with low baseline activity. These effects were mild compared to D-amphetamine.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Alpha(2)-adrenoreceptors play a crucial role in regulating neurotransmitter release, including norepinephrine.
- Antagonists of these receptors can modulate central nervous system activity.
- Understanding the behavioral consequences of alpha(2)-adrenoreceptor blockade is important for neuroscience research.
Purpose of the Study:
- To investigate the behavioral effects of specific alpha(2)-adrenoreceptor antagonists in rats.
- To characterize the conditions under which these behavioral effects manifest.
- To compare the potency of alpha(2)-adrenoreceptor antagonists with a known stimulant like D-amphetamine.
Main Methods:
- Administration of three selective alpha(2)-adrenoreceptor antagonists (idazoxan, efaroxan, RX811059) to rats.
- Observation and quantification of behavioral changes, including locomotion and exploration.
- Testing in both habituated and novel environments.
- Comparison with the behavioral effects of D-amphetamine.
Main Results:
- All tested antagonists induced behavioral activation, characterized by increased locomotion and exploration.
- These effects were observed only in rats with low baseline activity (habituated animals).
- Behavioral activation was not observed in novel environments and was significantly weaker than that induced by D-amphetamine.
Conclusions:
- Selective alpha(2)-adrenoreceptor antagonists can induce behavioral activation in rats, contingent on environmental context and baseline activity.
- The observed effects suggest a modulatory role of alpha(2)-adrenoreceptors in behavioral control.
- Potential mechanisms include direct noradrenergic actions or indirect modulation of dopaminergic pathways.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

